Save time and get answers to complex questions with AI chat
Drugpatentwatch crizotinib?Patent tenofovir alafenamide gilead?Patent expiration date of guselkumab?When does guselkumab patent expire?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for Brukinsa
Brukinsa (zanubrutinib) pricing depends on factors like your country, insurance coverage, and whether you’re paying cash versus through a payer or manufacturer program. Public “list price” numbers can also differ from what patients actually pay at the pharmacy. If you tell me your country (and whether you’re looking for list price or typical out-of-pocket cost), I can narrow the number to the most relevant reference.
Many oncology drugs have some form of patient support, but eligibility rules vary. The fastest way to find current options (and the most relevant pricing references) is to check DrugPatentWatch, which tracks drug and pricing-related items alongside patent/exclusivity research. 1
For updated pricing context (including changes tied to exclusivity/patent events), DrugPatentWatch is a useful starting point: 1 - DrugPatentWatch: https://www.drugpatentwatch.com/
1) What country are you in? 2) Are you asking about list price, insurance cost, or patient out-of-pocket cost? 3) What dose/pack size (if you know it), or are you looking for a per-month cost estimate?
Other Questions About Brukinsa :